Evidence-aware
Safety focused
Women’s Health Clinic FAQ
Can the O-Shot help leaking when sneezing?
Leaking when sneezing often fits a stress urinary incontinence pattern. The O-Shot may be discussed for selected patients, usually after confirming symptom type and severity, but it should sit within a broader plan that may include pelvic-floor assessment, menopause review, bladder advice, or referral if symptoms are complex.
Direct answer
Leaking when sneezing often fits a stress urinary incontinence pattern. The O-Shot may be discussed for selected patients, usually after confirming symptom type and severity, but it should sit within a broader plan that may include pelvic-floor assessment, menopause review, bladder advice, or referral if symptoms are complex.
The most useful plan starts with the underlying cause, not the treatment name. Your clinician should review symptoms, medical history, alternatives, expected benefits, limitations and safety.
Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.
At a glance
These are the main points to understand before deciding whether this option is suitable.
At a glance
Clinical summary
Mechanism of Action
Involves extracting your own blood, concentrating the platelets, and injecting the Platelet-Rich Plasma (PRP) into the anterior vaginal.
Suitability must be confirmed after consultation.
Suitability must be confirmed after consultation.
Suitability must be confirmed after consultation.
Suitability must be confirmed after consultation.
Suitability must be confirmed after consultation.
Suitability must be confirmed after consultation.
Important safety note
Safety Profile: Because PRP is derived from your own blood (autologous), the risk of allergic reactions or rejection is reduced, although not removed.
Suitability
Evidence
Safety
Aftercare
Detailed answer
Detailed answer
Investigational Status: Considered 'off-label' and not yet included in standard NICE or BSUG guidelines due to the need for larger randomised controlled trials. Variability in Results: High heterogeneity in outcomes due to different PRP preparation systems and individual patient healing responses.
Clinical context
Investigational Status: Considered 'off-label' and not yet included in standard NICE or BSUG guidelines due to the need for larger randomised controlled trials.
Evidence
Symptoms
Alternatives
What it means
Investigational Status: Considered 'off-label' and not yet included in standard NICE or BSUG guidelines due to the need for larger randomised controlled trials.
Why it happens
Symptoms may be linked to physical, hormonal, medication-related, psychological or relationship factors.
Evidence limits
Evidence may be developing, so the page should avoid promise-based language and explain uncertainty.
Treatment fit
Suitability depends on history, symptoms, examination where appropriate and discussion of alternatives.
What this means in practice
Setting: Outpatient, office-based procedure taking approximately 30 to 60 minutes. Costs should be confirmed on the /pricing/ page before booking
Initial Response (Days 3-7): Immediate change is often temporary while the healing cascade begins. Tissue Development (Week 1+): Regeneration and new blood vessel development accelerate over the following weeks.
Patient safety
Why proper assessment matters
Assessment helps separate marketing claims from safe, individualised clinical decision-making.
It checks the cause
Investigational Status: Considered 'off-label' and not yet included in standard NICE or BSUG guidelines due to the need for larger randomised controlled trials.
It protects safety
Safety Profile: Because PRP is derived from your own blood (autologous), the risk of allergic reactions or rejection is reduced, although not removed.
It reviews alternatives
Setting: Outpatient, office-based procedure taking approximately 30 to 60 minutes. Costs should be confirmed on the /pricing/ page before booking
It sets expectations
Initial Response (Days 3-7): Immediate change is often temporary while the healing cascade begins.
A clinical decision, not a shortcut
The safest final page should explain what the intervention may do, what it cannot promise, and when another route may be better.
Treatment should be discussed with realistic goals, informed consent, clear aftercare and a plan for review.
Considerations
What to consider
Setting: Outpatient, office-based procedure taking approximately 30 to 60 minutes. Costs should be confirmed on the /pricing/ page before booking
Consultation priorities
Step 1: Consultation, clinical history, and baseline symptom questionnaires to rule out underlying pathologies. Step 2: Topical numbing cream is applied 20 minutes before injections.
Consent
Aftercare
Follow-up
Before treatment
Step 1: Consultation, clinical history, and baseline symptom questionnaires to rule out underlying pathologies. Step 2: Topical numbing cream is applied 20 minutes before injections.
During care
The clinician should explain the procedure, likely sensations, limits and alternatives.
Aftercare
Written aftercare and follow-up should be clear before the patient leaves.
When to reassess
If expected improvement does not occur, the plan should be reviewed rather than repeated automatically.
Practical expectations
Initial Response (Days 3-7): Immediate change is often temporary while the healing cascade begins.
Costs, access and treatment plans should be confirmed before booking.
Common concerns and myths
Common misconceptions
Clear patient information should correct over-simple claims and keep expectations realistic.
Myth: Sneezing leakage is too small to mention.
Reality: suitability depends on the symptom pattern, medical history, contraindications, alternatives and individual goals.
Myth: All bladder leakage is treated the same way.
Reality: results vary, evidence may be developing, and non-response should prompt reassessment.
Myth: PRP removes the need for pelvic-floor assessment.
Reality: injections, devices and intimate procedures can still carry risks and need proper consent and aftercare.
Evidence and advertising
Marketing language should not outrun clinical evidence.
Alternatives
Setting: Outpatient, office-based procedure taking approximately 30 to 60 minutes. Costs should be confirmed on the /pricing/ page before booking
Safety checklist
Safety checklist
Use these questions to decide whether treatment should be discussed, delayed or redirected.
Has the cause been assessed?
Symptoms should be reviewed in context before selecting a treatment.
Are red flags absent?
Safety Profile: Because PRP is derived from your own blood (autologous), the risk of allergic reactions or rejection is reduced, although not removed.
Are alternatives clear?
Setting: Outpatient, office-based procedure taking approximately 30 to 60 minutes. Costs should be confirmed on the /pricing/ page before booking
Is follow-up planned?
The clinic should explain aftercare, review timing and when to seek help.
Reassuring signs
Proceeding is more reasonable when goals are clear, red flags have been checked, and expectations are realistic.
No red flags
Follow-up plan
Reasons to pause
Safety Profile: Because PRP is derived from your own blood (autologous), the risk of allergic reactions or rejection is reduced, although not removed.
Bleeding
Infection
When to escalate
When to seek medical help
Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online
Severe or worsening pain
Safety Profile: Because PRP is derived from your own blood (autologous), the risk of allergic reactions or rejection is reduced, although not removed.
Bleeding or discharge
Unexplained bleeding, unusual discharge or new pelvic symptoms should be reviewed.
Infection signs
Fever, spreading redness, pus or feeling unwell after a procedure needs urgent advice.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Benchmark positioning
- The winning page is practical and discreet: it answers the exact sneeze-leak question and guides the reader into proper assessment.
Clinical reality
- Investigational Status: Considered 'off-label' and not yet included in standard NICE or BSUG guidelines due to the need for larger randomised controlled trials.
Timeline and expectations
- Initial Response (Days 3-7): Immediate change is often temporary while the healing cascade begins. Tissue Development (Week 1+): Regeneration and new blood vessel development accelerate over the following weeks.
Practical logistics
- Setting: Outpatient, office-based procedure taking approximately 30 to 60 minutes. Costs should be confirmed on the /pricing/ page before booking
Research sources
- Utama, B. I., et al. (2026). 'Therapeutic efficacy and safety of injectable platelet-rich plasma in women with stress urinary incontinence: a systematic review and meta-analysis.' Frontiers in Medicine, 13:1728478.
- Jiang, Y. H. , et al. (2021). 'Therapeutic Efficacy of Urethral Sphincter Injections of Platelet-Rich Plasma for the Treatment of Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency: A Proof-of-Concept Clinical Trial.'
- Kochhar, N., & Tomar, A. (2026). 'A Prospective Pilot Interventional Study to Evaluate the Role of Platelet-Rich Plasma in Female Stress Urinary Incontinence.' CME Journal Geriatric Medicine, 18(5): 46-51.
Regulatory resources
Authoritative resources
These resources support assessment-led, evidence-aware patient information.
NICE guidance on vaginal laser for urogenital atrophy
NICE is a UK authority for interventional procedure governance and supports cautious language about evidence, consent and audit.
FDA safety communication on vaginal rejuvenation devices
This safety communication is a useful regulatory reference for avoiding over-claiming around sexual enhancement procedures.
RCOG patient information on menopause symptom treatment
RCOG patient information supports assessment-led discussion of vaginal dryness, discomfort and hormone-related symptoms.
Next step
Book a clinical consultation
A consultation can confirm whether this treatment may be suitable, whether another pathway should come first, and what realistic outcomes and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 144 imported records. Additional reviewed material included peer-reviewed clinical papers, evidence reviews, clinical trial records; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. Disclaimer: The information provided in this document is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. The O-Shot (PRP therapy) is currently an off-label, investigational procedure for stress urinary incontinence. Individual suitability must be determined by a qualified healthcare provider or urogynaecologist. Always consult your doctor before beginning any new medical treatment, and call emergency services if you experience a medical emergency. Results vary. Not a cure.
